期刊
JOURNAL OF HEPATOLOGY
卷 52, 期 4, 页码 594-604出版社
ELSEVIER
DOI: 10.1016/j.jhep.2009.10.033
关键词
Virus; Cancer; Hepatitis; Hepatocellular carcinoma; Oncogene; Tumour suppressor
资金
- Institut Pasteur
- Institut National de la Sante et de la Recherche Medicale (Inserm)
- Agence Nationale de Recherche sur le SIDA (ANRS)
- Association pour la Recherche sur le Cancer (ARC)
- Ligue Nationale contre le Cancer (LNCC)
The hepatitis B virus (HBV) is a small enveloped DNA virus, which primarily infects hepatocytes and causes acute and persistent liver disease. Epidemiological studies have provided overwhelming evidence for a causal role of chronic HBV infection in the development of hepatocellular carcinoma, but the molecular mechanisms underlying virally-induced tumourigenesis remain largely debated. In the absence of a dominant oncogene encoded by the HBV genome, indirect roles have been proposed, including insertional activation of cellular cancer-related genes by HBV DNA integration, induction of genetic instability by viral integration or by the regulatory protein HBx, and long-term effects of viral proteins in enhancing immune-mediated liver disease. Recent genetic studies indicate that HBV-related tumours display a distinctive profile with a high rate of chromosomal alterations and low frequency of beta-catenin mutations. This review will discuss the evidence implicating chronic HBV infection as a causal risk factor of primary liver cancer. It will also discuss the molecular mechanisms that are critical for the tumourigenic process due to long lasting infection with HBV. (c) 2009 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据